The use of research peptides outside of supervised research settings raises concerns about product quality, dosing accuracy, and lack of medical oversight
By binding to GLP-1 receptors, semaglutide enhances insulin secretion from pancreatic beta cells in a glucose-dependent manner, meaning it stimulates insulin release only when blood glucose levels are elevated
Pregnancy-specific plans help support blood sugar and weight without medication risks
With the right combination of medication, lifestyle changes, and clinical support, individuals may achieve significant fat loss and avoid surgical intervention
We offer a range of management strategies and individualized treatment plans, including lifestyle modifications, non-hormonal therapies, and hormone replacement therapy when appropriate